Validation of the Shoebox PureTest audiometry technology for remote data collection in clinical trials
At present, traditional audiologic assessments are required to be performed in clinics and present a considerable burden to patients and sites (e.g., cost, time), particularly in clinical trials that require numerous longitudinal visits. This study evaluated an iPad-based remote audiometry technology, the Shoebox PureTest, for accuracy and usability, and aimed to determine whether it is fit for use in research and clinical studies. In participants with a wide range of hearing sensitivity, the Shoebox PureTest audiometer was determined to be sufficiently accurate, reliable, and usable, and was statistically equivalent to gold-standard conventional audiometry assessments at frequencies of 500, 1000, 2000, and 4000 Hz. The user experience survey demonstrated that > 80% of users rated the application and usability as 'good', and the overall satisfaction was rated as 'excellent' by 92% of participants. Whilst there are operational considerations for future use in clinical trials, the Shoebox PureTest audiometer has been shown to be a valid alternative to conventional hearing assessments which can be used for the optimization of clinical research studies.
Authors
- Matthew F. Wipperman (ORCID: https://orcid.org/0000-0003-1436-3366)
- Alan R. Shuldiner (ORCID: https://orcid.org/0000-0001-9921-4305)
- Jacek Urbanek (ORCID: https://orcid.org/0000-0002-1890-8899)
- Meghan C. Drummond
- Pratyush Rai (ORCID: https://orcid.org/0000-0001-6525-5782)
- Erin Robertson
- Emily Redington (ORCID: https://orcid.org/0000-0002-6409-3360)
- Rolando Acosta
- Roland Barge
- Gannie Tzoneva
- Ramzi Majaj
Institutions
- Regeneron (United States) (US)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-06-12
- DOI
- https://doi.org/10.1038/s41598-026-49550-8
- Primary Topic
- Hearing Loss and Rehabilitation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Regeneron Pharmaceuticals